Human primary liver cancer–derived organoid cultures for disease modeling and drug screening

Broutier, Laura, Mastrogiovanni, Gianmarco, Verstegen, Monique MA, Francies, Hayley E, Gavarró, Lena Morrill, Bradshaw, Charles R, Allen, George E, Arnes-Benito, Robert +14 more·2017·Nature Medicine

Cited by (1,001)

Items 501–600 of 1,001

  1. Trends and challenges in organoid modeling and expansion with pluripotent stem cells and somatic tissue
    Jian-Yun Ge, Yun Wang, Qilin Li, Fan-Kai Liu, Quan-Kai Lei, Yun‐Wen Zheng · 2024 · PeerJ
  2. Organoids and spheroids: advanced in vitro models for liver cancer research
    Mirella Pastore, Alessia Giachi, Elena Spínola-Lasso, Fabio Marra, Chiara Raggi · 2025 · Frontiers in Cell and Developmental Biology
  3. Liver and Pancreas: Do Similar Embryonic Development and Tissue Organization Lead to Similar Mechanisms of Tumorigenesis?
    Elsa Ghurburrun, Ivan Borbath, Frédéric P. Lemaigre, Patrick Jacquemin · 2018 · Gene Expression
  4. Predictors of ribociclib-mediated antitumour effects in native and sorafenib-resistant human hepatocellular carcinoma cells
    Florian Paul Reiter, Gerald Denk, Andreas Ziesch, Andrea Ofner, Ralf Wimmer, Simon D. Hohenester, Tobias S. Schiergens, Matilde Pia Spampatti, Liangtao Ye, Timo Itzel et al. · 2019 · Cellular Oncology
  5. Therapeutic Potential of CUDC-907 (Fimepinostat) for Hepatocarcinoma Treatment Revealed by Tumor Spheroids-Based Drug Screening
    Wei Liao, Wanren Yang, Yue Zhang, Zeng FanHong, 徐杰诚, Zhengming Yan, Pan Mingxin, Xiaoping Xu, Shuqin Zhou, Min Zeng et al. · 2021 · Frontiers in Pharmacology
  6. Development of patient‑derived tumor organoids and a drug testing model for renal cell carcinoma
    Akira Kazama, Tsutomu Anraku, Hiroo Kuroki, Yuko Shirono, Masaki Murata, Vladimir N. Bilim, Andrey V. Ugolkov, Kazuhide Saito, Yoshihiko Tomita · 2021 · Oncology Reports
  7. The Potential Clinical Use of Stem/Progenitor Cells and Organoids in Liver Diseases
    Christina Nikokiraki, Adriana Psaraki, Maria G. Roubelakis · 2022 · Cells
  8. Patient-derived tumor organoids for personalized medicine in a patient with rare hepatocellular carcinoma with neuroendocrine differentiation: a case report
    Marie‐Anne Meier, Sandro Nuciforo, Mairene Coto‐Llerena, John Gallon, Matthias Sebastian Matter, Caner Ercan, Jürg Vosbeck, Luigi Terracciano, Savas Deniz Soysal, Daniel Tobias Boll et al. · 2022 · Communications Medicine
  9. MicroRNA-223 Suppresses Human Hepatic Stellate Cell Activation Partly via Regulating the Actin Cytoskeleton and Alleviates Fibrosis in Organoid Models of Liver Injury
    Chaiyaboot Ariyachet, Nattaya Chuaypen, Pornchai Kaewsapsak, Naphat Chantaravisoot, Depicha Jindatip, Saranyapin Potikanond, Pisit Tangkijvanich · 2022 · International Journal of Molecular Sciences
  10. Multi-compartment tumor organoids
    Meng‐Horng Lee, Gabriella C. Russo, Yohan Suryo Rahmanto, Wenxuan Du, Ashleigh J. Crawford, Pei‐Hsun Wu, Daniele M. Gilkes, Ashley L. Kiemen, Tsutomu Miyamoto, Yu Yu et al. · 2020 · Materials Today
  11. Cancer organoid applications to investigate chemotherapy resistance
    Kenji Harada, Naoya Sakamoto · 2022 · Frontiers in Molecular Biosciences
  12. Polymerization force–regulated actin filament–Arp2/3 complex interaction dominates self-adaptive cell migrations
    Xindong Chen, Yuhui Li, Ming Guo, Bowen Xu, Yanhui Ma, Hanxing Zhu, Xi‐Qiao Feng · 2023 · Proceedings of the National Academy of Sciences
  13. Human retinal organoids with an OPA1 mutation are defective in retinal ganglion cell differentiation and function
    Qiannan Lei, Kangjian Xiang, Lin Zhang Cheng, Mengqing Xiang · 2023 · Stem Cell Reports
  14. Emergence of Intrahepatic Cholangiocarcinoma: How High-Throughput Technologies Expedite the Solutions for a Rare Cancer Type
    Meng‐Shin Shiao, Khajeelak Chiablaem, Varodom Charoensawan, Nuttapong Ngamphaiboon, Natini Jinawath · 2018 · Frontiers in Genetics
  15. Gaining New Biological and Therapeutic Applications into the Liver with 3D In Vitro Liver Models
    Sang Woo Lee, Da Jung Jung, Gi Seok Jeong · 2020 · Tissue Engineering and Regenerative Medicine
  16. Liver organoids: Current advances and future applications for hepatology
    Kim, Yohan, Kang, Minseok, Mamo, Michael Girma, Adisasmita, Michael, Huch, Meritxell, Choi, Dongho · 2025 · Clinical and Molecular Hepatology
  17. The Patient-Derived Cancer Organoids: Promises and Challenges as Platforms for Cancer Discovery
    Bae, JuneSung, Choi, Yun Sik, Cho, Gunsik, Jang, Se Jin · 2022 · Cancers
  18. Patient-derived tumor models and their distinctive applications in personalized drug therapy
    Jia He, Chunhe Zhang, Aliçan Özkan, Tang Feng, Peiyan Duan, Shuo Wang, Xinrui Yang, Jing Xie, Xiaoheng Liu · 2023 · Mechanobiology in Medicine
  19. Patient-Derived Organoid Biobanks for Translational Research and Precision Medicine: Challenges and Future Perspectives
    Floriana Jessica Di Paola, Giulia Calafato, Pier Paolo Piccaluga, Giovanni Tallini, Kerry Jane Rhoden · 2025 · Journal of Personalized Medicine
  20. Artificial Intelligence Virtual Organoids (AIVOs)
    Long Bai, Jiacan Su · 2025 · Bioactive Materials
  21. Organoids for Liver Stage Malaria Research
    Ronan Mellin, Justin A. Boddey · 2019 · Trends in Parasitology
  22. The liver metastatic niche: modelling the extracellular matrix in metastasis
    James Drew, Laura M. Machesky · 2021 · Disease Models & Mechanisms
  23. Validation of Immunohistochemistry for Canine Proteins Involved in Thyroid Iodine Uptake and Their Expression in Canine Follicular Cell Thyroid Carcinomas (FTCs) and FTC-Derived Organoids
    Jana Jankovic, Martina Dettwiler, Martín González Fernández, Eve Tièche, Kerstin Hahn, Simon April-Monn, Matthias S. Dettmer, Martin Kessler, Sven Rottenberg, Miguel Campos · 2021 · Veterinary Pathology
  24. Upgrading a Consumer Stereolithographic 3D Printer to Produce a Physiologically Relevant Model with Human Liver Cancer Organoids
    Louise Breideband, Kaja Nicole Wächtershäuser, Levin Hafa, Konstantin Wieland, Achilleas S. Frangakis, Ernst H. K. Stelzer, Francesco Pampaloni · 2022 · Advanced Materials Technologies
  25. Epigenetic reactivation of tumor suppressor genes with CRISPRa technologies as precision therapy for hepatocellular carcinoma
    Agustin Sgro, Joseph Cursons, Charlene Babra Waryah, Eleanor Woodward, Momeneh Foroutan, Ruqian Lyu, George C. Yeoh, Peter J. Leedman, Pilar Blancafort · 2023 · Clinical Epigenetics
  26. Liver organoids: a promising three-dimensional model for insights and innovations in tumor progression and precision medicine of liver cancer
    Yukun Chen, Yujun Liu, Shimin Chen, Long Zhang, Jiawei Rao, Xinjun Lu, Yi Ma · 2023 · Frontiers in Immunology
  27. LANCL1, a cell surface protein, promotes liver tumor initiation through FAM49B-Rac1 axis to suppress oxidative stress
    Hongyang Huang, Yu‐Man Tsui, Daniel Wai‐Hung Ho, Clive Yik‐Sham Chung, Karen Man‐Fong Sze, Eva Lee, Gary Cheuk-Hang Cheung, Vanilla Xin Zhang, Xia Wang, Xueying Lyu et al. · 2023 · Hepatology
  28. Bioengineering Approaches for the Pancreatic Tumor Organoids Research and Application
    Taiyu Song, Bin Kong, Rui Liu, Yuan Luo, Yongan Wang, Yuanjin Zhao · 2023 · Advanced Healthcare Materials
  29. A multidimensional platform of patient-derived tumors identifies drug susceptibilities for clinical lenvatinib resistance
    Lei Sun, Arabella H. Wan, Shijia Yan, Ruonian Liu, Jiarui Li, Zhuolong Zhou, Ruirui Wu, Dongshi Chen, Xianzhang Bu, Jingxing Ou et al. · 2023 · Acta Pharmaceutica Sinica B
  30. Integrated characterization of hepatobiliary tumor organoids provides a potential landscape of pharmacogenomic interactions
    Yanjing Zhu, Shijie Tang, Qiuyue Yuan, Jing Fu, Juan He, Zhuang Liu, Xiaofang Zhao, Yunguang Li, Yan Zhao, Yani Zhang et al. · 2024 · Cell Reports Medicine
  31. Ultra-low content physio-chemically crosslinked gelatin hydrogel improves encapsulated 3D cell culture
    Saad Asim, Emma J. Hayhurst, Rachel Callaghan, Muhammad Rizwan · 2024 · International Journal of Biological Macromolecules
  32. Impact of mouse contamination in genomic profiling of patient-derived models and best practice for robust analysis
    Se‐Young Jo, Eun‐Young Kim, Sangwoo Kim · 2019 · Genome biology
  33. Harnessing the Potential of Stem Cells for Disease Modeling: Progress and Promises
    Chiara Argentati, Ilaria Tortorella, Martina Bazzucchi, Francesco Morena, Sabata Martino · 2020 · Journal of Personalized Medicine
  34. miR24‐2 accelerates progression of liver cancer cells by activating Pim1 through tri‐methylation of Histone H3 on the ninth lysine
    Yuxin Yang, Shuting Song, Qiuyu Meng, Liyan Wang, Xiaonan Li, Sijie Xie, Yingjie Chen, Xiaoxue Jiang, Chen Wang, Yanan Lu et al. · 2020 · Journal of Cellular and Molecular Medicine
  35. Organ‐Level Functional 3D Tissue Constructs with Complex Compartments and their Preclinical Applications
    Jaeseo Lee, DoYeun Park, Yoojin Seo, Justin Jihong Chung, Youngmee Jung, Soo Hyun Kim · 2020 · Advanced Materials
  36. Comparison of primary and passaged tumor cell cultures and their application in personalized medicine
    Pipiya, Vladislava V., Gilazieva, Zarema E., Issa, Shaza S., Rizvanov, Albert A., Solovyeva, Valeriya V. · 2024 · Exploration of Targeted Anti-tumor Therapy
  37. PDAC as an immune evasive disease: can 3D model systems aid to tackle this clinical problem?
    Narayanan, Shruthi, Vicent, Silve, Ponz-Sarvisé, Mariano · 2021 · Frontiers in Cell and Developmental Biology
  38. Identification and validation of tumor-specific T cell receptors from tumor infiltrating lymphocytes using tumor organoid co-cultures
    Zhilang Li, Lisha Ma, Zhaoya Gao, Xiya Wang, Xuan Che, Pengchong Zhang, Yixian Li, Qianjing Zhang, Tianxing Liu, Yuan Sun et al. · 2024 · Cancer Immunology Immunotherapy
  39. The biological macromolecules constructed Matrigel for cultured organoids in biomedical and tissue engineering
    Ke-yu Zhao, Yu Du, Huimin Cao, Liya Su, Xiulan Su, Xian Li · 2024 · Colloids and Surfaces B Biointerfaces
  40. Metabolic dysfunction-associated steatotic liver disease and steatohepatitis-associated hepatocarcinoma preclinical models
    Jack Leslie, Kishore Alagere Krishnamurthy, Indresh K Gopalsamy, Patrícia Inácio, Meritxell Huch, Suchira Gallage, Fiona Oakley, Michele Vacca · 2026 · Nature Reviews Gastroenterology & Hepatology
  41. Human liver organoids for disease modeling of fibrolamellar carcinoma
    Nicole J.C. Narayan, David Requena, Gadi Lalazar, Lavoisier S. Ramos-Espiritu, Denise Ng, Solomon Levin, Bassem Shebl, Ruisi Wang, William J. Hammond, James A. Saltsman et al. · 2022 · Stem Cell Reports
  42. An organoid library of salivary gland tumors reveals subtype-specific characteristics and biomarkers
    Bo Wang, Jiaxing Gan, Zhengyan Liu, Zhixuan Hui, Jinhui Wei, Xiaolian Gu, Yabing Mu, Guangxiang Zang · 2022 · Journal of Experimental & Clinical Cancer Research
  43. Establishment and characterization of canine mammary tumoroids for translational research
    Antonella Raffo‐Romero, Soulaimane Aboulouard, Emmanuel Bouchaert, Agata Marta Rybicka, Dominique Tierny, Nawale Hajjaji, Isabelle Fournier, Michel Salzet, Marie Duhamel · 2023 · BMC Biology
  44. Histone‐lysine N‐methyltransferase EHMT2 (G9a) inhibition mitigates tumorigenicity in Myc‐driven liver cancer
    Dexter Kai Hao Thng, Lissa Hooi, Clarissa Chin Min Toh, Jhin Jieh Lim, Deepa Rajagopalan, Imran Qamar Charles Syariff, Zher Min Tan, Masturah Bte Mohd Abdul Rashid, Lei Zhou, Alfred Wei Chieh Kow et al. · 2023 · Molecular Oncology
  45. Exploring New Dimensions of Tumor Heterogeneity: The Application of Single Cell Analysis to Organoid‐Based 3D In Vitro Models
    Natalie Landon‐Brace, Nancy T. Li, Alison P. McGuigan · 2023 · Advanced Healthcare Materials
  46. Unveiling Epigenetic Vulnerabilities in Triple-Negative Breast Cancer through 3D Organoid Drug Screening
    Xinxin Rao, Zhibin Qiao, Yang Yang, Yun Deng, Zhen Zhang, Xiaoli Yu, Xiaomao Guo · 2024 · Pharmaceuticals
  47. Liver stem cells: Plasticity of the liver epithelium
    Atsunori Tsuchiya, Wei‐Yu Lu · 2019 · World Journal of Gastroenterology
  48. Cholangiocarcinoma Disease Modelling Through Patients Derived Organoids
    Francesco Amato, Colin J. Rae, Maria Giuseppina Prete, Chiara Braconi · 2020 · Cells
  49. Signalling pathways and transcriptional regulators orchestrating liver development and cancer
    Campbell, Stephanie A., Stephan, Tabea L., Lotto, Jeremy, Cullum, Rebecca, Drissler, Sibyl, Hoodless, Pamela A. · 2021 · Development
  50. Feasibility analysis of using patient-derived tumour organoids for treatment decision guidance in locally advanced head and neck squamous cell carcinoma
    Anne-Sophie Fisch, Ana Pestana, Vanessa Sachse, Christian Doll, Elena Hofmann, Max Heiland, Theresa Obermueller, Jan Heidemann, Steffen Dommerich, Diana Schoppe et al. · 2024 · European Journal of Cancer
  51. A New Perspective on Precision Medicine: The Power of Digital Organoids
    Qian Yang, Mengmeng Li, Zian Xiao, Yekai Feng, Lanjie Lei, Shisheng Li · 2025 · Biomaterials Research
  52. Human Organoids and Their Application in Tumor Models, Disease Modeling, and Tissue Engineering
    Siyuan Song, Zheng Liu, Yi Wang, Bo Gong · 2025 · Medicine Bulletin
  53. WNT–β-catenin signalling in hepatocellular carcinoma: from bench to clinical trials
    Brandon M. Lehrich, Satdarshan P. Monga · 2025 · Nature Reviews Gastroenterology & Hepatology
  54. Hepatic bile acid synthesis and secretion: Comparison of in vitro methods
    Véronique M P de Bruijn, Zhenguo Wang, Wouter Bakker, Weijia Zheng, Bart Spee, Hans Bouwmeester · 2022 · Toxicology Letters
  55. Tumor Organoid Model and Its Pharmacological Applications in Tumorigenesis Prevention
    Xiaolei Cao, Wenjie Zheng, Yuwei Qiang, Ninghua Yao, Fan Zuo, Shi Qiu · 2022 · Current Molecular Pharmacology
  56. Will Organoids Fill the Gap towards Functional Precision Medicine?
    Federica Papaccio, Manuel Cabeza-Segura, Blanca García-Micó, Noelia Tarazona, Desamparados Roda, Josefa Castillo, Andrès M.R. Cervantes · 2022 · Journal of Personalized Medicine
  57. Organoids of the male reproductive system: Challenges, opportunities, and their potential use in fertility research
    Daniela Patrício, Joana Santiago, João Filipe Mano, Margarida Fardilha · 2022 · WIREs Mechanisms of Disease
  58. Organoids technology for advancing the clinical translation of cancer nanomedicine
    Dong‐Kun Zhao, Jie Liang, Xiao‐Yi Huang, Song Shen, Jun Wang · 2023 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
  59. Mapping the Potential of Microfluidics in Early Diagnosis and Personalized Treatment of Head and Neck Cancers
    Sangeeth Pillai, Jan C. Kwan, Fares Yaziji, Hanwen Yu, Simon D. Tran · 2023 · Cancers
  60. Application Prospect of Induced Pluripotent Stem Cells in Organoids and Cell Therapy
    Teng Zhang, Cheng Qian, Mengyao Song, Yu Tang, Yueke Zhou, Guanglu Dong, Qiuhong Shen, Wenxing Chen, Aiyun Wang, Sanbing Shen et al. · 2024 · International Journal of Molecular Sciences
  61. Mouse Models of Oncoimmunology in Hepatocellular Carcinoma
    Erin R. Bresnahan, Katherine E. Lindblad, Marina Ruiz de Galarreta, Amaia Lujambio · 2020 · Clinical Cancer Research
  62. Protein synthesis inhibitor omacetaxine is effective against hepatocellular carcinoma
    Ling Li, Gilad Halpert, Michael G. Lerner, Hai‐Jie Hu, Peter Michael Dimitrion, Matthew John Weiss, Jin Peng He, Benjamin Philosophe, Richard Andrew Burkhart, William Reece Burns et al. · 2021 · JCI Insight
  63. MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study
    Eriseld Krasniqi, Andrea Sacconi, Daniele Marinelli, Laura Pizzuti, Marco Mazzotta, Domenico Sergi, Elisabetta Maria Capomolla, Sara Donzelli, Mariantonia Carosi, Anna Bagnato et al. · 2021 · Biomarker Research
  64. Leveraging Patient-Derived Organoids for Personalized Liver Cancer Treatment
    Jianhua Rao, Chao Song, Yangyang Hao, Zaozao Chen, Sidu Feng, Shihui Xu, Xiaoyue Wu, Zhengfeng Xuan, Ye Fan, Wenzhu Li et al. · 2024 · International Journal of Biological Sciences
  65. Organoids technology in cancer research: from basic applications to advanced ex vivo models
    Luca Varinelli, Oscar Illescas, Ewelina Lorenc, Davide Battistessa, Marzia Di Bella, Susanna Zanutto, Manuela Gariboldi · 2025 · Frontiers in Cell and Developmental Biology
  66. Prediction of CAR‐T Therapy In Vitro: Development of Biomimetic Models for CAR‐T Killing Effect Assessment
    Xuan Sun, Zilin Zhang, Wentao Zhao, Shihui Xu, Jing Zhang, Xue-Mei ZhuanSun, Jiexian Ye, Yanyan Han, Zhongze Gu, Zaozao Chen · 2025 · Small
  67. Advances in liver and pancreas organoids: how far we have come and where we go next
    Aleksandra Sljukic, Joshua Green Jenkinson, Armin Niksic, Nicole Prior, Meritxell Huch · 2025 · Nature Reviews Gastroenterology & Hepatology
  68. Tissue-Engineered Bile Ducts for Disease Modeling and Therapy
    Zhenguo Wang, João Faria, Louis C. Penning, Rosalinde Masereeuw, Bart Spee · 2020 · Tissue Engineering Part C Methods
  69. Organoids for the Study of Liver Cancer
    Haichuan Wang, Diego Francesco Calvisi, Xin Chen · 2021 · Seminars in Liver Disease
  70. Novel organoid model in drug screening: Past, present, and future
    Xialin Nie, Zhixing Liang, Kun Li, Haoyuan Yu, Yu‐Han Huang, Linsen Ye, Yang� Yang · 2021 · Liver Research
  71. The Application of Induced Pluripotent Stem Cells Against Liver Diseases: An Update and a Review
    Lei Zhang, Ke Pu, Xiaojun Liu, Sarah Da Won Bae, Romario Nguyen, Suyang Bai, Yi Li, Liang Qiao · 2021 · Frontiers in Medicine
  72. Metformin sensitises hepatocarcinoma cells to methotrexate by targeting dihydrofolate reductase
    Yinghui Wang, Hui Juan Lu, Linchong Sun, Xin Chen, Haoran Wei, Caixia Suo, Junru Feng, Mengqiu Yuan, Shengqi Shen, Weidong Jia et al. · 2021 · Cell Death and Disease
  73. ERK1/2 inhibits Cullin 3/SPOP-mediated PrLZ ubiquitination and degradation to modulate prostate cancer progression
    Yizeng Fan, Tao Hou, Weichao Dan, Yasheng Zhu, Bo Liu, Yi Wei, Zixi Wang, Yang Gao, Jin Zeng, Lei Li · 2022 · Cell Death and Differentiation
  74. Liver Organoids, Novel and Promising Modalities for Exploring and Repairing Liver Injury
    Chiyu He, Di Lu, Zuyuan Lin, Hao Hui Chen, Huigang Li, Xinyu Yang, Modan Yang, Kai Wang, Xuyong Wei, Shusen Zheng et al. · 2022 · Stem Cell Reviews and Reports
  75. Patient-derived models facilitate precision medicine in liver cancer by remodeling cell-matrix interaction
    Kaiwen Chen, Yanran Li, Bingran Wang, Xuehan Yan, Yiying Tao, Weizhou Song, Zhifeng Xi, Kang He, Qiang Xia · 2023 · Frontiers in Immunology
  76. Advancements in 3D In Vitro Models for Colorectal Cancer
    Sara Vitale, Federica Calapà, Francesca Colonna, Francesca Luongo, Mauro Biffoni, Ruggero D. Maria, Micol Eleonora Fiori · 2024 · Advanced Science
  77. Clinically relevant inflammatory breast cancer patient-derived xenograft–derived ex vivo model for evaluation of tumor-specific therapies
    Bedrich L. Eckhardt, Maria Ester Gagliardi, LaKesla R. Iles, Kurt W. Evans, Cristina Ivan, Xiuping Liu, Chang‐Gong Liu, Glauco R. Souza, Arvind U.K. Rao, Funda Meric‐Bernstam et al. · 2018 · PLoS ONE
  78. Generation of liver bipotential organoids with a small-molecule cocktail
    Xin Wang, Chao Ni, Ning Jiang, Jinsong Wei, Jianqing Liang, Bing Tian Zhao, Xinhua Lin · 2020 · Journal of Molecular Cell Biology
  79. Ciprofloxacin promotes polarization of CD86+CD206‑ macrophages to suppress liver cancer
    Mengtian Fan, Sicheng Chen, Yaguang Weng, Xian Li, Yingjiu Jiang, Xiaowen Wang, Mengjun Bie, Liqin An, Menghao Zhang, Bin Chen et al. · 2020 · Oncology Reports
  80. Breast cancer organoids and their applications for precision cancer immunotherapy
    Dandan Guan, Xiaozhen Liu, Qingyang Shi, Bangjie He, Chaopeng Zheng, Xuli Meng · 2023 · World Journal of Surgical Oncology
  81. Patient-derived Organoids in Bladder Cancer: Opportunities and Challenges
    Martina Radić, Martin Egger, Marianna Kruithof‐de Julio, Roland Seiler · 2024 · European Urology Focus
  82. New developments and applications of human organoids
    Amanda Andersson-Rolf, Hans C. Clevers · 2026 · Nature Reviews Molecular Cell Biology
  83. Establishment and characterization of meningioma patient-derived organoid
    Henry Siu Cheung Chan, Ho‐Keung Ng, Aden Ka‐Yin Chan, Sau Ha Cheng, Chit Chow, Nathalie Wong, George Kwok Chu Wong · 2021 · Journal of Clinical Neuroscience
  84. Human induced-T-to-natural killer cells have potent anti-tumour activities
    Zhiwu Jiang, Le Qin, Yuou Tang, Rui Jin Liao, Jingxuan Shi, Bingjia He, Shanglin Li, Diwei Zheng, Yuanbin Cui, Qiting Wu et al. · 2022 · Biomarker Research
  85. Impact of baseline culture conditions of cancer organoids when determining therapeutic response and tumor heterogeneity
    Rebecca A. DeStefanis, Jeremy D. Kratz, Autumn M. Olson, Aishwarya Sunil, Alyssa K. DeZeeuw, Amani A. Gillette, Gioia Chengcheng Sha, Katherine Anne Johnson, Cheri A. Pasch, Linda J. Clipson et al. · 2022 · Scientific Reports
  86. Recent advances and challenges in organoid-on-a-chip technology
    Intan Rosalina Suhito, Taehyung P. Kim · 2022 · Organoid
  87. Biomimetic epithelium/endothelium on chips
    Lina Lin, Xiaocheng Wang, Mengying Niu, Qiaolin Wu, Huan Wang, Yan Zu, Weijian Wang · 2022 · Engineered Regeneration
  88. Investigation of reversible histone acetylation and dynamics in gene expression regulation using 3D liver spheroid model
    Stephanie Stransky, Ronald R. Cutler, Jennifer T. Aguilan, Edward Nieves, Simone Sidoli · 2022 · Epigenetics & Chromatin
  89. The tumor microenvironment and immune targeting therapy in pediatric renal tumors
    Amy B Hont, Benoît Dumont, Kathryn S. Sutton, John Anderson, Alex Kentsis, Jarno Drost, Andrew Lee Hong, Arnauld C. Verschuur · 2022 · Pediatric Blood & Cancer
  90. An Automation Workflow for High‐Throughput Manufacturing and Analysis of Scaffold‐Supported 3D Tissue Arrays
    Ruonan Cao, Nancy T. Li, Simon Latour, Jose L. Cadavid, Cassidy M Tan, Ari Forman, Hartland Warren Jackson, Alison P. McGuigan · 2023 · Advanced Healthcare Materials
  91. A quick and reliable image-based AI algorithm for evaluating cellular senescence of gastric organoids
    Ruixin Yang, Yutong Du, Wingyan Kwan, Ranlin Yan, Qimeng Shi, Lu Zang, Zhenggang Zhu, Jianming Zhang, Chen Li, Yingyan Yu · 2023 · Cancer Biology and Medicine
  92. Alternative Splicing of lncRNAs From SNHG Family Alters snoRNA Expression and Induces Chemoresistance in Hepatoblastoma
    Ni Zhen, Jiabei Zhu, Siwei Mao, Qi Zhang, Song Gu, Ji Ma, Yue Zhang, Minzhi Yin, Haojie Li, Nan Jing Huang et al. · 2023 · Cellular and Molecular Gastroenterology and Hepatology
  93. Knockdown of lncRNA MALAT1 induces pyroptosis by regulating the miR‑124/SIRT1 axis in cervical cancer cells
    Tian Liang, Tong Lu, Weiwei Jia, R. Li, Min Jiang, Jiao Yu, Yuchen Wang, Shanshan Cong, Xinyan Jiang, Lina Dong et al. · 2023 · International Journal of Oncology
  94. Engineering Heterogeneous Tumor Models for Biomedical Applications
    Zhuhao Wu, Danqing Huang, Jinglin Wang, Yuanjin Zhao, Weijian Sun, Xian Shen · 2023 · Advanced Science
  95. A Decade of Organoid Research: Progress and Challenges in the Field of Organoid Technology
    Basheer Ahammed, Suresh Kumar Kalangi · 2024 · ACS Omega
  96. Organoids have opened avenues into investigating numerous diseases. But how well do they mimic the real thing?
    Helen H. Shen · 2018 · Proceedings of the National Academy of Sciences
  97. Development of a system combining comprehensive genotyping and organoid cultures for identifying and testing genotype-oriented personalised medicine for pancreatobiliary cancers
    Masahiro Shiihara, Tomohiko Ishikawa, Yuriko Saiki, Yuko Omori, Katsuya Hirose, Shinichi Fukushige, Naoki Ikari, Ryota Higuchi, Masakazu Yamamoto, Takanori Morikawa et al. · 2021 · European Journal of Cancer
  98. Advances in organoid-on-a-chip for recapitulation of human physiological events
    Bum Jun Park, Junseo Park, Sanghun Han, Taeyeon Kwon, Ju Yong Sung, Jigyeong Kim, Moein Safarkhani, Kyung-Hyun Min, Eun-Ho Lee, Sung‐Min Kang et al. · 2025 · Materials Today
  99. Rational design matrix materials for organoid development and application in biomedicine
    Yue Fei Huang, Xiaoyu Zhang, Wanjun Zhang, Jinglong Tang, Jing Liu · 2025 · Regenerative Biomaterials
  100. Hepatic organoids as a platform for liver disease modeling and the development of novel therapies
    Eléanor Luce, Antonietta Messina, Jean‐Charles Duclos‐Vallée · 2025 · Clinics and Research in Hepatology and Gastroenterology